Biocon's biologics arm gets EU GMP certificate for new facility in Bengaluru Biocon revealed that the EU GMP certificate is for the new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru, following a GMP inspection in April 2022.
Biocon's biologics arm gets EU GMP certificate for new facility in Bengaluru
- Konuyu başlatan Bilgin
- Başlangıç tarihi